Advanced search
Publication Cover
Future Oncology Volume 13, 2017 - Issue 11
Submit an article Journal homepage
86
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Resectable pancreatic adenocarcinomas: will neoadjuvant FOLFIRINOX replace upfront surgery in the standard of care?

Amine Antonios1 Surgery Department, Faculty of Medicine,Saint Joseph University,Beirut,LebanonCorrespondence[email protected]
,
Joseph Gharios1 Surgery Department, Faculty of Medicine,Saint Joseph University,Beirut,Lebanon
&
Cyril Tohme1 Surgery Department, Faculty of Medicine,Saint Joseph University,Beirut,Lebanon
Pages 951-953 | Received 01 Feb 2017, Accepted 28 Feb 2017, Published online: 08 May 2017

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.